跳至主要内容
临床试验/EUCTR2014-004357-13-DK
EUCTR2014-004357-13-DK进行中(未招募)1 期

Coagaulation in patients with atrial fibrillation: The effect of dabigatran

Odense University Hospital0 个研究点开始时间: 2015年2月24日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients with atrial fibrillation
  • 1. Patients with non-valvular atrial fibrillation, who are to begin dabigatran treatment
  • 2. Age = 18 years
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 15
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • 1. Persons, who can not give informed consent
  • 2. treatment with platelet inhibitors, heparin, warfarin, direct anti-xa inhibitors or other medical therapy or supplements that may affect blod coagulation processes.
  • 3. change in the other medication within 14 days before enrollment

研究者

相似试验